Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 


A new 2013 research report extends the benefit of BLIS K12™

From: BLIS Technologies Ltd (NZX:BLT)

MediaPak: National Pak

Date: Friday, 11 Dec 2013

Release: Immediate

A new 2013 research report extends the benefit of BLIS K12™ probiotic

BLIS Technologies Ltd (NZX:BLT) announces another clinical study, just published this month, which further supports the effectiveness of BLIS K12™ oral cavity probiotic for preventing ear and throat infections. Published in the medical science journal, Expert Opinion on Biological Therapy, an Italian research team demonstrated that they could prevent the reoccurrence of common ear and throat infections, such as strep throat infection and tonsillitis by more than 83% in adults. The study followed 40 adults with a history of recurrent ear and throat infection and examined the effect of 90 days of treatment with either the BLIS K12™ probiotic or a placebo. Researchers concluded “The regular use of BLIS K12 appears to have effected a substantial reduction in the incidence of recurrent oral streptococcal pathology, reducing the requirement for these BLIS K12-treated individuals to be exposed to therapeutic courses of antibiotics.”

Di Pierro, F., et al. (2013). Clinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults. Expert Opinion on Biological Therapy.

This paper has been published just two months after a similar research paper also concluded that regular use of BLIS K12 in children could reduce the incidence of strep throat infection (including tonsillitis) by more than 92%. The children examined in this earlier study, previously had a recurrence rate for strep throat infection of nearly 4 times per year, however those children who then were assigned to the treatment with the BLIS K12™ probiotic dropped dramatically their rate of infection to the equivalent of just one incidence, every 4 years.

BLIS Technologies CEO, Dr Barry Richardson said, “We have known from our own work over several years about the effectiveness of the BLIS K12™ probiotic in treating and preventing certain infections of the throat and upper airways but finally, we have an independent research group that has now corroborated these findings. It is reassuring to us to know that BLIS K12™ has been independently supported as being highly efficacious in both children and adults.”

Dr Richardson said that he has seen a growing awareness among healthcare professional in New Zealand, pharmacists, dentist and doctors of benefits of BLIS K12™ probiotic for mouth and throat and has seen an increasing acceptance to consider BLIS K12™ probiotic as an option when managing the health of their patients, both young and old.

www.blis.co.nz

ENDS

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Royal Society: Review Finds Community Water Fluoridation Safe And Effective

A review of the scientific evidence for and against the efficacy and safety of fluoridation of public water supplies has found that the levels of fluoridation used in New Zealand create no health risks and provide protection against tooth decay. More>>

ALSO:

Scoop Business: Croxley Calls Time On NZ Production In Face Of Cheap Imports

Croxley Stationery, whose stationery brands include Olympic, Warwick and Collins, plans to cease manufacturing in New Zealand because it has struggled to compete with lower-cost imports in a market where the printed word is giving way to electronic communications. More>>

ALSO:

Prefu Roundup: Forecasts Revised, Surplus Intact

The National government heads into the election with its Budget surplus target broadly intact, delivering a set of economic and fiscal forecasts marginally revised from May to reflect weaker commodity prices and a lower tax take. More>>

ALSO:

Convention Centre: Major New SkyCity Hotel And Laneway For Auckland

Today SKYCITY Entertainment Group Limited revealed plans to build a new hotel and pedestrian laneway of bars, restaurants and boutique shopping on land it owns in the Nelson and Hobson Streets block, expanding the SKYCITY Entertainment Precinct. More>>

ALSO:

Igniting The Spark: Bringing The Digital Enabler To Life

Changing a name is, relatively speaking, the easy part of a re-invention. Changing a culture, getting all the ducks in a row, turning yourself inside-out to become customer-inspired is a much bigger challenge. More>>

ALSO:

Ebola And NZ: Targeted Screening At Airport But Risk Low

The risk of any cases of Ebola in New Zealand remains very low, but health and border authorities are well prepared... anyone arriving in New Zealand who in the last three weeks has visited countries affected will be screened for symptoms of the disease. More>>

ALSO:

Scoop Business: Brewer Seeking Crowd-Funding Cancels Shareholders’ Dividends

Shareholders in Renaissance Brewing company, the first business to seek equity through crowd-funding in New Zealand, have cancelled their claim on $147,000 of accumulated earnings “to make Renaissance a more attractive investment opportunity.” More>>

ALSO:

Get More From Scoop

 
 
Computer Power Plus

Standards New Zealand

Standards New Zealand
 
 
 
 
 
 
 
 
Business
Search Scoop  
 
 
Powered by Vodafone
NZ independent news